EyePoint, Inc (EYPT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $34.82M
Last updated: Nov 17, 2026 at 11:05 AM ET
EyePoint, Inc (EYPT) Stock Forecast
Analysts expect EyePoint (EYPT) to earn -$3.62 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.70M. Of 13 analysts, 3 rate the stock Buy or Strong Buy, 9 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 5 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 13 ratings average 2.92, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 23% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 3 | 23.1% |
| Hold | 9 | 69.2% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 7.7% |
- Consensus
- Hold
- Total analysts
- 13
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 126.5%.
- Fiscal year ending Dec 31, 2026
- -$3.62
- EPS consensus, revenue $1.70M
- Fiscal year ending Dec 31, 2027
- -$2.07
- EPS consensus, revenue $3.85M
- Next report
- Mar 2, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$3.62 | -$4.24 to -$2.68 | 11 | $1.70M | $1.00M to $2.70M | 13 |
| Dec 31, 2027 | -$2.07 | -$4.14 to -$0.72 | 11 | $3.85M | N/A | 13 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.69 | -$0.91 to -$0.38 | 15 | $309845 | N/A | 15 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 9 upward and 3 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 5 | 2 |
| Fiscal year ending Dec 31, 2027 | 4 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$3.55.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$3.62 | -$3.62 | -$3.72 | -$3.72 | -$3.55 | N/A |
| Fiscal year ending Dec 31, 2027 | -$2.07 | -$2.20 | -$2.77 | -$2.77 | -$3.04 | N/A |
Frequently Asked Questions About EYPT
What is the EYPT stock forecast?
Consensus analyst estimates put EyePoint's EPS at -$3.62 for the fiscal year ending Dec 31, 2026, on revenue of $1.70M. The consensus rating from 13 analysts is Hold.
How do analysts rate EYPT stock?
Of 13 analysts covering EyePoint, 0 rate it Strong Buy, 3 Buy, 9 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from EYPT next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.62, with estimates from -$4.24 to -$2.68 from 11 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.07, with estimates from -$4.14 to -$0.72 from 11 analysts.
What revenue do analysts expect from EyePoint next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.70M, with estimates from $1.00M to $2.70M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $3.85M.
How many analysts cover EYPT?
13 analysts rate EyePoint stock, and 11 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
EYPT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors